PFND
Pathfinder Cell Therapy Inc
Price:
0
USD
Volume:
2,730
United States | Biotechnology
PFND ROE (Return on Equity)
As of 2025-05-24, the ROE (Return on Equity) of Pathfinder Cell Therapy Inc (PFND) is 23.5%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
PFND ROE (Return on Equity) - Historical Value
| Date | Value |
|---|---|
| 2014-12-31 | 23.5% |
| 2013-12-31 | 37.5% |
| 2012-12-31 | 75.6% |
| 2011-12-31 | 1594.1% |
| 2010-12-31 | 115% |
| 2009-12-31 | -487.3% |
| 2008-12-31 | -151.7% |
| 2007-12-31 | -163.8% |
| 2006-12-31 | -117.1% |
| 2005-12-31 | -1653.8% |
PFND ROE (Return on Equity) - Peers Comparison